Reneo
Reneo is the leading end-to-end asset transformation- & decarbonization platform for residential real estate in Germany
About Reneo
Reneo is a pharmaceutical company that is developing treatments for patients with rare genetic mitochondrial diseases. These diseases often happen when the mitochondria can’t produce enough energy (ATP) for the body.
Legal Name
: Reneo
Headquarters
: , Germany
Business Model
:
Founding Date
: 1970
No. of Employees
:
Founding Members
Related Post
Reneo funding news – Hamburg-based Reneo Secures €600 Million in Funding
Europe Weekly Startup Funding News Report For Monday, 10 March 2025 to Saturday, 15 March 2025
February 2025 Funding Recap
Contact us: contact@startuprise.co.uk